Where Oak HC/FT in­vestor Nan­cy Brown is plac­ing her bets on AI in health tech

9 months ago
Startups
AI

WuXi AppTec more than tripled lob­by­ing spend as Biose­cure Act ad­vanced in Con­gress

9 months ago
China
Law

Blue­bird bio hand­ed neg­a­tive opin­ion from fed­er­al over­sight agency for fer­til­i­ty sup­port pro­gram

9 months ago
Pharma
FDA+

Up­dat­ed: Sam­sung wins FDA ap­proval for sec­ond Soliris biosim­i­lar

9 months ago
Pharma
FDA+

North Car­oli­na's Med­ic­aid pro­gram to cov­er weight loss drugs be­gin­ning in Au­gust

9 months ago
Pharma

Sino Bio­phar­m's in­voX to re­struc­ture, like­ly cut­ting about 60 roles

9 months ago
People

Ag­i­lent Tech­nolo­gies to ac­quire CD­MO Biovec­tra for $925M

9 months ago
Deals
Manufacturing

HI-Bio dish­es on mo­ti­va­tions for Bio­gen buy­out, cit­ing de­sire to move fast

9 months ago
Deals

Chi­nese biotech boasts com­pet­i­tive Phase 2b weight loss da­ta for GLP-1 drug

9 months ago
R&D

Grü­nen­thal inks a deal with Vali­nor; Val­ne­va gets $41M from CEPI

9 months ago
News Briefing

Lay­offs at Rapt Ther­a­peu­tics af­ter wind­ing down mid-stage tri­als of lead drug

10 months ago
People

SEC staff rec­om­mends en­force­ment ac­tion against Al­lar­i­ty over po­ten­tial fed­er­al se­cu­ri­ties laws vi­o­la­tions

10 months ago
Law

Io­n­is flash­es new An­gel­man syn­drome da­ta, will pur­sue Phase 3 tri­al next year

10 months ago
R&D

A rare dis­ease first; Lil­ly’s Alzheimer’s push; Ar­genx’s next act; No­var­tis' obe­si­ty ap­proach; and more

10 months ago
Weekly

Chi­na ap­proves Eli Lil­ly's weight loss drug as coun­try launch­es obe­si­ty aware­ness cam­paign

10 months ago
China
Pharma

Ver­mont at­tor­ney gen­er­al sues two ma­jor PBMs for al­leged­ly dri­ving up costs

10 months ago
Pharma

EMA re­asserts dif­fer­ences with FDA for Covid vac­cine strain se­lec­tion

10 months ago
FDA+
Coronavirus

US inks $113M deal with Siga to bol­ster small­pox, mpox re­serves

10 months ago
Pharma

Eu­ro­pean Com­mis­sion pres­i­dent’s sec­ond-term pledge: sim­pler reg­u­la­tions, bet­ter fund­ing and tack­ling short­ages

10 months ago
Pharma

Rona Ther­a­peu­tics rais­es $35M; Ac­tu­ate now plans for $22M IPO

10 months ago
News Briefing

Or­biMed forms biotech with as­sets from Chi­na-based Keymed, en­lists for­mer Bio­haven ex­ec as CEO

10 months ago
Financing
Startups

Roivant re­cent­ly sold one spin­out for bil­lions. Is Pri­o­vant next?

10 months ago
Deals
R&D

Cor­rect­ed: Lil­ly upped its of­fer for Mor­phic by $11 per share, doc­u­ments show

10 months ago
Deals
Pharma

Nadir Mah­mood re­turns to Nkar­ta a year af­ter leav­ing; BeiGene picks long­time Mer­ck ex­ec for CFO post

10 months ago
People
Peer Review
First page Previous page 120121122123124125126 Next page Last page
A service from the Financial Times